J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, and R. Rozmahel, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, pp.1066-1073, 1989.

L. Saiman and J. Siegel, Infection control in cystic fibrosis, Clin Microbiol Rev, vol.17, pp.57-71, 2004.

C. Chaparro, J. Maurer, C. Gutierrez, M. Krajden, and C. Chan, Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation, Am J Respir Crit Care Med, vol.163, pp.43-48, 2001.

G. B. Rogers, C. A. Hart, J. R. Mason, M. Hughes, and M. J. Walshaw, Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling, J Clin Microbiol, vol.41, pp.3548-3558, 2003.

A. Van-belkum, N. H. Renders, S. Smith, S. E. Overbeek, and H. A. Verbrugh, Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients, FEMS Immunol Med Microbiol, vol.27, pp.51-57, 2000.

N. Wellinghausen, J. Kothe, B. Wirths, A. Sigge, and S. Poppert, Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis, J Clin Microbiol, vol.43, pp.4070-4075, 2005.

P. Vaudaux, W. L. Kelley, and D. P. Lew, Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat, Clin Infect Dis, vol.43, pp.968-970, 2006.

J. D. Mcmenamin, T. M. Zaccone, T. Coenye, P. Vandamme, and J. J. Lipuma, Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates, Chest, vol.117, pp.1661-1665, 2000.

G. B. Rogers, M. P. Carroll, D. J. Serisier, P. M. Hockey, and G. Jones, characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling, J Clin Microbiol, vol.42, pp.5176-5183, 2004.

M. Kolak, F. Karpati, H. J. Monstein, and J. Jonasson, Molecular typing of the bacterial flora in sputum of cystic fibrosis patients, Int J Med Microbiol, vol.293, pp.309-317, 2003.

J. K. Harris, M. A. De-groote, S. D. Sagel, E. T. Zemanick, and R. Kapsner, Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis, Proc Natl Acad Sci U S A, vol.104, pp.20529-20533, 2007.

F. Fenollar, V. Roux, A. Stein, M. Drancourt, and D. Raoult, Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections, J Clin Microbiol, vol.44, pp.1018-1028, 2006.

M. Sakamoto, I. N. Rocas, J. F. Siqueira, and Y. Benno, Molecular analysis of bacteria in asymptomatic and symptomatic endodontic infections, Oral Microbiol Immunol, vol.21, pp.112-122, 2006.

D. Saito, R. T. Leonardo, J. L. Rodrigues, S. M. Tsai, and J. F. Hofling, Identification of bacteria in endodontic infections by sequence analysis of 16S rDNA clone libraries, J Med Microbiol, vol.55, pp.101-107, 2006.

H. J. Rolph, A. Lennon, M. P. Riggio, W. P. Saunders, and D. Mackenzie, Molecular identification of microorganisms from endodontic infections, J Clin Microbiol, vol.39, pp.3282-3289, 2001.

B. J. Paster, S. K. Boches, J. L. Galvin, R. E. Ericson, and C. N. Lau, Bacterial diversity in human subgingival plaque, J Bacteriol, vol.183, pp.3770-3783, 2001.

P. S. Kumar, A. L. Griffen, M. L. Moeschberger, and E. J. Leys, Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis, J Clin Microbiol, vol.43, pp.3944-3955, 2005.

G. Hutter, U. Schlagenhauf, G. Valenza, M. Horn, and S. Burgemeister, Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens, Microbiology, vol.149, pp.67-75, 2003.

F. K. Bahrani-mougeot, B. J. Paster, S. Coleman, S. Barbuto, and M. T. Brennan, Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia, J Clin Microbiol, vol.45, pp.1588-1593, 2007.

J. A. Aas, B. J. Paster, L. N. Stokes, I. Olsen, and F. E. Dewhirst, Defining the normal bacterial flora of the oral cavity, J Clin Microbiol, vol.43, pp.5721-5732, 2005.

G. B. Rogers, M. P. Carroll, D. J. Serisier, P. M. Hockey, and G. Jones, Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis, J Clin Microbiol, vol.44, pp.2601-2604, 2006.

M. M. Tunney, T. R. Field, T. F. Moriarty, S. Patrick, and G. Doering, Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis, Am J Respir Crit Care Med, vol.177, pp.995-1001, 2008.

S. Shakil, R. Khan, R. Zarrilli, and A. U. Khan, Aminoglycosides versus bacteriaa description of the action, resistance mechanism, and nosocomial battleground, J Biomed Sci, 2007.

L. A. Jewes and R. C. Spencer, The incidence of anaerobes in the sputum of patients with cystic fibrosis, J Med Microbiol, vol.31, pp.271-274, 1990.

K. Duan, C. Dammel, J. Stein, H. Rabin, and M. G. Surette, Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication, Mol Microbiol, vol.50, pp.1477-1491, 2003.

P. K. Singh, A. L. Schaefer, M. R. Parsek, T. O. Moninger, and M. J. Welsh, Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms, Nature, vol.407, pp.762-764, 2000.

D. Hill, B. Rose, A. Pajkos, M. Robinson, and P. Bye, Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions, J Clin Microbiol, vol.43, pp.5085-5090, 2005.

D. J. Hassett, J. Cuppoletti, B. Trapnell, S. V. Lymar, and J. J. Rowe, Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets, Adv Drug Deliv Rev, vol.54, pp.1425-1443, 2002.

S. S. Yoon, R. F. Hennigan, G. M. Hilliard, U. A. Ochsner, and K. Parvatiyar, Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis, Dev Cell, vol.3, pp.593-603, 2002.

N. Hoffmann, B. Lee, M. Hentzer, T. B. Rasmussen, and Z. Song, Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr / Mice, Antimicrob Agents Chemother, vol.51, pp.3677-3687, 2007.

T. Coenye, J. Goris, T. Spilker, P. Vandamme, and J. J. Lipuma, Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov, J Clin Microbiol, vol.40, pp.2062-2069, 2002.

R. Chiron, H. Marchandin, F. Counil, E. Jumas-bilak, and A. M. Freydiere, Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis, J Clin Microbiol, vol.43, pp.3938-3943, 2005.
DOI : 10.1128/jcm.43.8.3938-3943.2005
URL : http://jcm.asm.org/content/43/8/3938.full.pdf

N. Wellinghausen, A. Essig, and O. Sommerburg, Inquilinus limosus in patients with cystic fibrosis, Germany. Emerg Infect Dis, vol.11, pp.457-459, 2005.

C. Pitulle, D. M. Citron, B. Bochner, R. Barbers, and M. D. Appleman, Novel bacterium isolated from a lung transplant patient with cystic fibrosis, J Clin Microbiol, vol.37, pp.3851-3855, 1999.

S. Schmoldt, P. Latzin, J. Heesemann, M. Griese, and A. Imhof, Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response, J Med Microbiol, vol.55, pp.1425-1433, 2006.
DOI : 10.1099/jmm.0.46466-0
URL : http://jmm.microbiologyresearch.org/deliver/fulltext/jmm/55/10/1425.pdf?itemId=/content/journal/jmm/10.1099/jmm.0.46466-0&mimeType=pdf&isFastTrackArticle=

R. P. Cooke, O. Neill, W. A. Xu, J. Moore, J. E. Elborn et al., Inquilinus limosus isolated from a cystic fibrosis patient: first UK report, Br J Biomed Sci, vol.64, pp.127-129, 2007.
DOI : 10.1080/09674845.2007.11732772

F. Bittar, A. Leydier, E. Bosdure, A. Toro, and M. Reynaud-gaubert, Inquilinus limosus and cystic fibrosis, Emerg Infect Dis, vol.14, pp.993-995, 2008.
DOI : 10.3201/eid1406.071355
URL : https://hal.archives-ouvertes.fr/hal-01478698

L. Laclaire and R. Facklam, Antimicrobial susceptibility and clinical sources of Dolosigranulum pigrum cultures, Antimicrob Agents Chemother, vol.44, pp.2001-2003, 2000.
DOI : 10.1128/aac.44.7.2001-2003.2000
URL : http://aac.asm.org/content/44/7/2001.full.pdf

A. Hoedemaekers, T. Schulin, B. Tonk, W. J. Melchers, and P. D. Sturm, Ventilator-associated pneumonia caused by Dolosigranulum pigrum, J Clin Microbiol, vol.44, pp.3461-3462, 2006.
DOI : 10.1128/jcm.01050-06
URL : http://jcm.asm.org/content/44/9/3461.full.pdf

H. Lecuyer, J. Audibert, A. Bobigny, C. Eckert, and C. Janniere-nartey, Dolosigranulum pigrum Causing Nosocomial Pneumonia and Septicemia, J Clin Microbiol, vol.45, pp.3474-3475, 2007.
DOI : 10.1128/jcm.01373-07
URL : http://jcm.asm.org/content/45/10/3474.full.pdf

F. Morio, H. Jean-pierre, L. Dubreuil, E. Jumas-bilak, and L. Calvet, Antimicrobial susceptibilities and clinical sources of Dialister species, Antimicrob Agents Chemother, 2007.
DOI : 10.1128/aac.00538-07
URL : http://aac.asm.org/content/51/12/4498.full.pdf

W. G. Weisburg, S. M. Barns, D. A. Pelletier, and D. J. Lane, 16S ribosomal DNA amplification for phylogenetic study, J Bacteriol, vol.173, pp.697-703, 1991.
DOI : 10.1128/jb.173.2.697-703.1991
URL : http://jb.asm.org/content/173/2/697.full.pdf